Spirepoint Private Client’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Buy
51,095
+115
+0.2% +$16.7K 0.61% 45
2026
Q1
$7.36M Buy
50,980
+212
+0.4% +$32.1K 0.7% 40
2025
Q4
$7.28M Sell
50,768
-39,955
-44% -$5.89M 0.7% 42
2025
Q3
$13.9M Buy
90,723
+2,499
+3% +$390K 1.47% 13
2025
Q2
$14.1M Buy
88,224
+69
+0.1% +$11.3K 1.59% 14
2025
Q1
$15M Buy
88,155
+1,925
+2% +$322K 1.96% 9
2024
Q4
$14.5M Buy
86,230
+4,258
+5% +$725K 1.81% 10
2024
Q3
$14.2M Buy
81,972
+2,167
+3% +$368K 1.88% 8
2024
Q2
$13.2M Buy
79,805
+2,212
+3% +$362K 1.87% 11
2024
Q1
$12.6M Buy
+77,593
New +$12.2M 1.92% 9

Other funds holding PG

Spirepoint Private Client's PG Position: Q2 2026 in Review

Spirepoint Private Client increased its Procter & Gamble (PG) stake by 0.23% in Q2 2026, buying an estimated $16.7K and bringing the position to 51,095 shares worth $7.49M. The position accounts for 0.61% of the portfolio, ranked #45.

Spirepoint Private Client first reported a position in PG in Q1 2024 and has held it in 10 quarters since. The position peaked at $15M in Q1 2025. 3,999 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Spirepoint Private Client held 51,095 shares of Procter & Gamble worth $7.49M as of Q2 2026.
  • Spirepoint Private Client bought 115 Procter & Gamble shares in Q2 2026, an estimated $16.7K.
  • Procter & Gamble made up 0.61% of Spirepoint Private Client's portfolio in Q2 2026, its #45 holding.
  • Spirepoint Private Client first reported a position in Procter & Gamble in Q1 2024 and has held it in 10 quarters since.
  • Spirepoint Private Client's Procter & Gamble position peaked at $15M in Q1 2025.
  • 3,999 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.